Literature DB >> 11903181

Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review.

D G Walker1, A H Kaye.   

Abstract

Low-grade gliomas are a diverse group of neoplasms which, as the name implies, are thought to arise from glial cells. Common among this group are astrocytomas (low-grade astrocytoma; LGA), oligodendrogliomas and mixed gliomas. Among these, LGA is the commonest low-grade glioma and, occasionally, although incorrectly, the terms are used interchangeably. Advances in imaging technology have improved the accuracy of preoperative diagnosis. The management of low-grade gliomas is controversial. Recent evidence suggests that previously considered standard therapy (i.e. surgery plus radiotherapy) may not be in the patient's best interests. A review of the available published research concerning low-grade gliomas is therefore timely.

Entities:  

Mesh:

Year:  2001        PMID: 11903181     DOI: 10.1046/j.1440-1673.2001.00959.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  13 in total

1.  Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas?

Authors:  Matthew L White; Yan Zhang; Patricia Kirby; Timothy C Ryken
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

2.  Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.

Authors:  Zhengping Zhuang; Meng Qi; Jie Li; Hiroaki Okamoto; David S Xu; Rajiv R Iyer; Jie Lu; Chunzhang Yang; Robert J Weil; Alexander Vortmeyer; Russell R Lonser
Journal:  J Neurosurg       Date:  2011-06-17       Impact factor: 5.115

3.  Inhibition of T-type Ca²⁺ channels by endostatin attenuates human glioblastoma cell proliferation and migration.

Authors:  Yuan Zhang; Junhong Zhang; Dongsheng Jiang; Dong Zhang; Zhiyuan Qian; Chunfeng Liu; Jin Tao
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

4.  [MR perfusion and spectroscopic imaging in WHO grade II astrocytomas].

Authors:  M-A Weber; M Vogt-Schaden; O Bossert; F L Giesel; H-U Kauczor; M Essig
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

5.  Central neurocytoma: a clinicopathological and neuroradiological study.

Authors:  Bo Zhang; Boning Luo; Zhongwei Zhang; Gengxi Sun; Jianming Wen
Journal:  Neuroradiology       Date:  2004-10-29       Impact factor: 2.804

Review 6.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

7.  Prognostic significance of astrocyte elevated gene-1 in human astrocytomas.

Authors:  Zhangxiu He; Meihui He; Chao Wang; Baozhan Xu; Liping Tong; Junming He; Bowen Sun; Lanlan Wei; Ming Chu
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

8.  Supportive care needs of people with brain tumours and their carers.

Authors:  Monika Janda; Elizabeth G Eakin; Lucy Bailey; David Walker; Kate Troy
Journal:  Support Care Cancer       Date:  2006-05-19       Impact factor: 3.359

9.  Sclerosing Meningioma : Radiological and Clinical Characteristics of 21 Cases.

Authors:  Ho Kang; Jin Wook Kim; Young-Bem Se; Yun-Sik Dho; Seung Hong Choi; Sung-Hye Park
Journal:  J Korean Neurosurg Soc       Date:  2016-10-24

10.  Postoperative functional status in patients with supratentorial superficial low-grade glioma.

Authors:  Ji Zhang; Yin Sheng Chen; You-Ping Li; Zheng-Quan Zhu; Jian-Min Liu; Cheng-Cheng Guo; Qun-Ying Yang; Xiao-Li Wang; Ying-Hua Rao; Qing Mao; Wen-Yan Li; Lu Ma; Yun Qiang Yang; Shi-Yin Xiao
Journal:  World J Surg Oncol       Date:  2017-10-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.